LighthouseTM Medical Emergency Medication:
Diphenhydramine HCl Injection 50 mg/mL
Guidelines have been established to help doctors and staff members adequately prepare for the immediate and effective management of life-threatening situations.
With HANSAmed being the sole provider and distributor of LIGHTHOUSETM across Canada, we have developed different solutions to accommodate all dental clinical medical emergency needs.
Diphenhydramine HCl injection: is Benadryl in the injectable form, an antihistamine drug. It is effective in adults and pediatric patients, other than premature infants and neonates, for the following conditions when Benadryl in the oral form is impractical.
- For amelioration of allergic reactions to blood or plasma, in anaphylaxis as an adjunct to epinephrine and other standard measures after the acute symptoms have been controlled, and for other uncomplicated allergic conditions of the immediate type when oral therapy is impossible or contraindicated.
- For active treatment of motion sickness.
- For use in parkinsonism, when oral therapy is impossible or contraindicated.
- Diphenhydramine HCl injection is for intravenous or intramuscular administration only.
- Benadryl in the injectable form is indicated when the oral form is impractical.
Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit.
Dosage should be individualized according to the needs and the response of the patient.
Pediatric patients: other than premature infants and neonates: 5 mg/kg/24 hr – maximum daily dosage is 300 mg. Divide into four doses, administered intravenously at a rate generally not exceeding 25 mg/min, or deep intramuscularly.
Adult patients: 10 to 50 mg intravenously at a rate generally not exceeding 25 mg/min, or deep intramuscularly, 100 mg if required; maximum daily dosage is 400 mg.
Diphenhydramine HCl has an atropine-like action and therefore, should be used with caution in patients with a history of bronchial asthma, increased intraocular pressure, hyperthyroidism, cardiovascular disease or hypertension.
Use with caution in patients with lower respiratory disease, including asthma.
Patients taking diphenhydramine hydrochloride should be advised that this drug may cause drowsiness and has an additive effect with alcohol. Patients should be warned about engaging in activities requiring mental alertness such as driving a car or operating appliances, machinery, etc.
Information retrieved from: